Quarterly Results

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma
BSE258.25-13.55 (-4.99 %)
PREV CLOSE ( ) 271.80
OPEN PRICE ( ) 258.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 40211
TODAY'S LOW / HIGH ( )258.25 258.25
52 WK LOW / HIGH ( )178.1 474
NSE257.35-13.55 (-5 %)
PREV CLOSE( ) 270.90
OPEN PRICE ( ) 257.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 257.35 (1122322)
VOLUME 592866
TODAY'S LOW / HIGH( ) 257.35 257.35
52 WK LOW / HIGH ( )178.8 472.8
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Audited / UnAudited
UnAudited
UnAudited
Net Sales
138.6
211.8
Total Expenditure
1164.8
1126.5
PBIDT (Excl OI)
-1026.2
-914.7
Other Income
63.9
84.9
Operating Profit
-962.3
-829.8
Interest
2.6
2.6
Exceptional Items
NA
NA
PBDT
-964.9
-832.4
Depreciation
31.6
31.8
Profit Before Tax
-996.5
-864.2
Tax
NA
NA
Provisions and contingencies
NA
NA
Profit After Tax
-996.5
-864.2
Extraordinary Items
NA
NA
Prior Period Expenses
NA
NA
Other Adjustments
NA
NA
Net Profit
-996.5
-864.2
Minority Interest
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
Consolidated Net Profit
-996.5
-864.2
Equity Capital
324.5
324.5
Face Value (IN RS)
1
1
Reserves
NA
NA
Calculated EPS
-3.07
-2.66
Calculated EPS (Annualised)
-12.28
-10.65
No of Public Share Holdings
111406493
111406493
% of Public Share Holdings
34.33
34.33
 
NA
NA
PBIDTM% (Excl OI)
-740.40
-431.86
PBIDTM%
-694.30
-391.78
PBDTM%
-696.17
-393.01
PBTM%
-718.97
-408.02
PATM%
-718.97
-408.02
 
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.